Cannabis Law Report

OCTOBER 2, 2021

The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable, and accessible work environment. European Regulatory Lead Executive Summary. Key Responsibilities.

Clinical Trials 52

Clinical Trials Research and Development Compliance Compliance 52

Cannabis Law Report

JULY 28, 2021

MAPS PBC strives to continually improve upon the supportive, equitable and accessible work environment. The individual in this position supports global regulatory programs, projects, and compliance initiatives across regions and business units. Experience working for a clinical study Sponsor.

Clinical Trials 81

Clinical Trials Research and Development Data Environment 81

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems. Active FDA Regulated Clinical Trials*. On March 5, 2019, the U.S. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

AUGUST 21, 2019

In November 2018, the legal status of cannabis was changed to allow specialist clinicians to legally prescribe cannabis-derived medicinal products to patients with an exceptional clinical need, following a high-profile media campaign. The final guideline is expected to be published in November 2019.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

FEBRUARY 5, 2022

Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. Communicate with regulatory bodies and global team.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

DECEMBER 15, 2021

Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. Communicate with regulatory bodies and global team.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

JANUARY 9, 2019

The largest cause of death in South Pacific females is cervical cancer; as there is little or no access to chemotherapy or radiotherapy. Tindall also hope to commence the clinical trials with Vanuatu for diabetes treatment. It’s all about access and education,” said Tindall. “If It’s hysterectomy or death,” said Tindall.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

NOVEMBER 13, 2019

Denmark is already leading the way by launching a Big Pharma modelled 4-year medical marijuana trial in early 2018, following a unanimous vote in Parliament. This ground-breaking trial has full parliamentary support, and will be evaluated in mid-2020. The roadmap ahead includes clinical trials and more research in Denmark.

Clinical Trials 78

Clinical Trials Research and Development Cultivation Patients 78

Cannabis Law Report

OCTOBER 26, 2019

ii Non-clinical studiesAlthough the use of animals in research is separately regulated by each state and territory, all require compliance with the Australian Code for the Care and Use of Animals for Scientific Purposes (Animal Code). One such circumstance is a clinical trial. medical practitioner), an organisation (e.g.,

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Cannabis Law Report

OCTOBER 10, 2021

Cantourage is an innovative company ensuring that patients are able to access the newest medicinal products based on cannabis. Provide guidance on clinical trials and plays integral role in bringing new product innovations to different markets in Europe (and beyond). pharmacology, toxicology, chemistry).

Clinical Trials 52

Clinical Trials Therapy Medicine Pharmaceutical 52

Cannabis Law Report

JULY 14, 2021

ImmunoFlex” ), today announced that it has completed and analyzed its clinical trial of 21 patients, aged 60 to 70 years. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. For more information, visit www.Chemistree.ca. federal law.

Research and Development 81

Research and Development Clinical Trials Events Treatment 81

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. These dispensaries operate under strict regulations to ensure compliance with the TCUP guidelines.

Law 52

Law Clinical Trials Dispensary Programs 52

Veriheal

OCTOBER 13, 2020

Dronabinol is commonly used as a treatment in cancer patients due to the fact that it can decrease gut transit and increase colon compliance. Luckily, Dronabinol can be organically accessed in its botanical form, THC, directly from the plant. .

Digestion 124

Digestion Treatment Conditions Research and Development 124

Cannabis Law Report

JANUARY 19, 2022

GMP psilocybin previously manufactured by Psygen personnel in collaboration with a licensed dealer using Psygen’s methods has already been used in clinical trials for development of therapeutic products. “A primary application for psychedelics is to support psychotherapy for treatment of mental health conditions.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Conditions 52

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable and accessible work environment. Deputy General Counsel Executive Summary.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Cannabis Law Report

NOVEMBER 29, 2019

Different legislation across EU countries on prescribing cannabis-based medicines can hinder patients’ access to their treatment when they travel abroad, EUMCA said. Lack of clinical trials is a major reason why doctors are cautious about the drug.

Medicine 45

Medicine Clinical Trials Treatment Access 45

MMJ Recs

APRIL 1, 2024

Furthermore, ongoing clinical trials are investigating CBD’s efficacy in treating conditions such as multiple sclerosis, Parkinson’s disease, and substance abuse disorders. CBD Oil for Medical Conditions CBD oil has gained popularity as a versatile and accessible option for managing various medical conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

MARCH 29, 2022

Former Moderna Vice President and Managing Director for North America recruited to prepare MAPS PBC for patient access and commercialization of the first psychedelic-assisted therapy anticipated to be approved by the FDA. has joined MAPS PBC as Head of Market Access. Dawn Lundin, M.S. , Theresa Gorenc, M.P.H. ,

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Access 52

Cannabis Law Report

MARCH 2, 2020

The UK government has eased import restrictions on medicinal cannabis, but has admitted it needs to do much more to improve access for patients. It will continue to engage with medical associations and patients to build evidence, using trials in the UK to accelerate our understanding of how medicinal cannabis can benefit patients.

Medicine 45

Medicine Research and Development Clinical Trials Patients 45

The Cannigma

FEBRUARY 11, 2021

The Cannabis Enigma Podcast is a co-production of Americans for Safe Access and The Cannigma. You know, started doing clinical trials through Zelda Therapeutics, and all the other things I’ve done. But we can also, back to what I said in my presentation today about compliance and what’s required for compliance.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

MMJ Recs

JULY 3, 2024

This variability can pose challenges for medical marijuana patients seeking consistent access to safe and effective CBD products, as well as for businesses aiming to comply with a patchwork of state laws. Image by Suzy Hazelwood on Pexels. Further research is needed to clarify these aspects and expand CBD’s therapeutic applications.

CBD 52

CBD Research and Development Clinical Trials THC 52

Cannabis Law Report

DECEMBER 7, 2021

The listing on the FSE enables Labat Healthcare, access to capital from retail and institutional investors in international markets. Chief Executive Officer of Labat Healthcare, Stanton van Rooyen said, “our intention is to offer South African and international investors exposure to high growth investments in the cannabis value chain.

Clinical Trials 52

Clinical Trials Medicine Cannabis Pharmaceutical 52

Cannabis Law Report

JULY 15, 2019

Law 33/2018 set the framework for the regulation of the use of cannabis-based medicinal products, preparations and substances that would effectively allow Portuguese patients to access medical cannabis What really has changed during the last year? The hardest part has already been done.

Medicine 40

Medicine Clinical Trials Patients Access 40

Cannabis Law Report

JUNE 9, 2022

The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. “ 8) Article 17 shall be worded as follows: Article 17.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. Prior to joining Sesen Bio, Mr. Barbera served as the Vice President of Market Access at UroGen Pharma and played a critical role in the launch of the company’s first commercial product, Jelmyto ®. Julie Hoff to Vice President, Human Resources.

Research and Development 51

Research and Development Treatment Pharmaceutical Patients 51

MMJ Recs

DECEMBER 22, 2023

This shift can be attributed to increased access to information, a more liberal societal outlook, and a willingness to explore alternative healthcare options. Peer-reviewed studies, clinical trials, and meta-analyses have played a crucial role in dispelling myths and misconceptions surrounding medical marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

DECEMBER 21, 2021

Facilitating workforce proof of health compliance data, Dalrada Health’s CLIA-certified laboratory provides on-site concierge services and holds national capability. Yet, more than half of the people in the least developed countries lack access to electricity. billion in 2019 Q3. DALRADA SUPPORTS WORLD INITIATIVES.

Research and Development 40

Research and Development Supply Chain Data Business 40

Cannabis Law Report

FEBRUARY 28, 2020

The International Narcotics Control Board (INCB) exists to monitor compliance with the international drug treaties our countries are bound by, including the 1961 Single Convention on Narcotic Drugs; the main agreement covering cannabis. From bad to worse. Perhaps we can rectify this in the Second Edition?

Law 59

Law Research and Development Recreational Cannabis 59

Cannabis Law Report

MAY 29, 2022

Clinical Trials and Human Subject Protections. Before the drug approval process even begins, sponsors must initiate clinical investigations by first filing an Investigational New Drug Application (IND) with FDA. FDA’s approval of an IND will also require sufficient evidence that the trial will be safe for human subjects.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JUNE 3, 2022

Legal Counsel (life sciences) clinical, regulatory, licensing New York Reporting to General Counsel, the Legal Counsel (life sciences) will be responsible for providing legal support and advice regarding all COMPASS clinical, regulatory and licensing matters. Manage compliance matters handled by outside counsel and consultants.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

Cannabis Law Report

MARCH 1, 2022

Legal Counsel (life sciences) clinical, regulatory, licensing New York Reporting to General Counsel, the Legal Counsel (life sciences) will be responsible for providing legal support and advice regarding all COMPASS clinical, regulatory and licensing matters. Manage compliance matters handled by outside counsel and consultants.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

OCTOBER 2, 2021

Reporting to General Counsel, the Legal Counsel (life sciences) will be responsible for providing legal support and advice regarding all COMPASS clinical, regulatory and licensing matters. COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

OCTOBER 15, 2021

Solutech™ is one of the fastest-acting, most bioavailable and comprehensively studied delivery systems for cannabinoids, including THC and CBD, uniquely differentiated for relative oral bioavailability and absorption by a Phase I human clinical trial.

Seed-To-Sale 52

Seed-To-Sale Cultivation Clinical Trials Cannabinoids 52

Cannabis Law Report

OCTOBER 17, 2019

“By passing the Cannabis Act, Canada has taken a position of principled non-compliance with its international drug treaty obligations,” says Fraser. They don’t want to disallow access to the only thing that may stop epileptic seizures in children or is part of a patient’s treatment plan.” There are only so many Canadian consumers.”.

Law 40

Law Seed-To-Sale Hemp Recreational 40